The relationship between pulse waveform analysis indices, endothelial function and clinical outcomes in patients with peripheral artery disease treated using percutaneous transluminal angioplasty during a one-year follow-up period.
The aim of the current study was to assess the relationship between potential predictors of clinical outcomes after percutaneous transluminal angioplasty (PTA) of peripheral arteries during a one-year follow-up. Indices of endothelial function (EF), arterial pulse waveform analysis (aPWA) and markers of peripheral arteries ischemia were among those mostly examined. The study comprised of 72 individuals with PAD who underwent PTA of the peripheral arteries. During the first visit and 1 and 6 months after PTA, endothelial function and aPWA measurements were performed. Ankle-brachial index (ABI), toe-brachial index (TBI) and physical evaluation of the limbs took place during the first visit and 1, 6 and 12 months after the PTA. The study endpoints included myocardial infarction, amputation, death, stroke and reintervention. All subjects included into the study were observed for 386 days after the PTA. We noticed significant improvement in walking distance after PTA, as well as transient improvement of ABI and flow-mediated dilatation (FMD), and no significant changes in aPWA indices or reactive-hyperemia index (RHI). There were 25 study endpoints which occurred in 16 patients during the follow-up period (22.2%). Patients with CLI, hypercholesterolemia, lower diastolic blood pressure, higher subendocardial viability ratio, greater number of pack-years and lower TBI at baseline presented significantly poorer clinical outcomes in terms of endpoint events. Endothelial function assessed as FMD and RH-PAT before PTA in patients with advanced PAD does not predict clinical outcomes during the one-year follow-up. < p > < /p >.